Clinical significance of monitoring E2APBX1 fusion gene expresion in patients with allogeneic hemato

• 作 者: 赵晓甦
• 机 构: Peking Univ People's Hosp,Peking Univ Hematol Instit,
• 出 处: China Medical Abstracts(Internal Medicine)
• 发表日期: 2016年01期
• 关键词: allogeneic hematopoietic enhancer lymphoblastic immunoglobulin transplant valuat

Objective To investigate the clinical characteristics of E2A-PBX1(immunoglobulin enhancer binding factor-pre-B leukemia)fusion gene in patients with acute lymphoblastic leukemia(ALL)after allogeneic stem cell transplantation(allo-HSCT).Methods Clinical data of

Objective To investigate the clinical characteristics of E2A-PBX1 (fusion protein in immunoglobulin enhancer binding factor-pre-B leukemia) fusion gene in patients with acute lymphoblastic leukemia (ALL) after allogeneic stem cell transplantation (allo-HSCT). Methods Clinical data of